A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition

The investigation of marine natural products (MNPs) as key resources for the discovery of drugs to mitigate the COVID-19 pandemic is a developing field. In this work, computer-aided drug design (CADD) approaches comprising ligand- and structure-based methods were explored for predicting SARS-CoV-2 main protease (Mpro) inhibitors. The CADD ligand-based method used a quantitative structure–activity relationship (QSAR) classification model that was built using 5276 organic molecules extracted from the ChEMBL database with SARS-CoV-2 screening data. The best model achieved an overall predictive accuracy of up to 67% for an external and internal validation using test and training sets. Moreover, based on the best QSAR model, a virtual screening campaign was carried out using 11,162 MNPs retrieved from the Reaxys® database, 7 in-house MNPs obtained from marine-derived actinomycetes by the team, and 14 MNPs that are currently in the clinical pipeline. All the MNPs from the virtual screening libraries that were predicted as belonging to class A were selected for the CADD structure-based method. In the CADD structure-based approach, the 494 MNPs selected by the QSAR approach were screened by molecular docking against Mpro enzyme. A list of virtual screening hits comprising fifteen MNPs was assented by establishing several limits in this CADD approach, and five MNPs were proposed as the most promising marine drug-like leads as SARS-CoV-2 Mpro inhibitors, a benzo[f]pyrano[4,3-b]chromene, notoamide I, emindole SB beta-mannoside, and two bromoindole derivatives.

[1]  Susana P. Gaudêncio,et al.  Enriching cancer pharmacology with drugs of marine origin , 2020, British journal of pharmacology.

[2]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[3]  M. Middelboe,et al.  Marine Viruses: Key Players in Marine Ecosystems , 2017, Viruses.

[4]  Sankalp Jain,et al.  Comparing the performance of meta-classifiers—a case study on selected imbalanced data sets relevant for prediction of liver toxicity , 2018, Journal of Computer-Aided Molecular Design.

[5]  Susana P. Gaudêncio,et al.  A Chemoinformatics Approach to the Discovery of Lead-Like Molecules from Marine and Microbial Sources En Route to Antitumor and Antibiotic Drugs , 2014, Marine drugs.

[6]  V Kumar,et al.  Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases , 2020, SAR and QSAR in environmental research.

[7]  Adolfo B Poma,et al.  Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment , 2020, Journal of biomolecular structure & dynamics.

[8]  Joshua S Weitz,et al.  Re-examination of the relationship between marine virus and microbial cell abundances , 2016, Nature Microbiology.

[9]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[10]  A. N. El-hoshoudy Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation , 2020, Journal of Molecular Liquids.

[11]  Susana P. Gaudêncio,et al.  The Madeira Archipelago As a Significant Source of Marine-Derived Actinomycete Diversity with Anticancer and Antimicrobial Potential , 2016, Front. Microbiol..

[12]  N. Krstulović,et al.  Distribution of marine viruses in the Central and South Adriatic Sea , 2014 .

[13]  Douglas E. V. Pires,et al.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.

[14]  Robert P. Sheridan,et al.  Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..

[15]  M. Gleeson Generation of a set of simple, interpretable ADMET rules of thumb. , 2008, Journal of medicinal chemistry.

[16]  Shuwen Liu,et al.  Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 , 2020, Acta Pharmacologica Sinica.

[17]  Susana P. Gaudêncio,et al.  Intra‐clade metabolomic profiling of MAR4 Streptomyces from the Macaronesia Atlantic region reveals a source of anti‐biofilm metabolites , 2019, Environmental microbiology.

[18]  Florbela Pereira,et al.  Computational Methodologies in the Exploration of Marine Natural Product Leads , 2018, Marine drugs.

[19]  Susana P. Gaudêncio,et al.  In Silico HCT116 Human Colon Cancer Cell-Based Models En Route to the Discovery of Lead-Like Anticancer Drugs , 2018, Biomolecules.

[20]  Huan Sun,et al.  Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease , 2020, Nature Communications.

[21]  Susana P. Gaudêncio,et al.  Antifouling Napyradiomycins from Marine-Derived Actinomycetes Streptomyces aculeolatus † , 2020, Marine drugs.

[22]  Susana P. Gaudêncio,et al.  A Computer-Driven Approach to Discover Natural Product Leads for Methicillin-Resistant Staphylococcus aureus Infection Therapy , 2018, Marine drugs.

[23]  Florbela Pereira Have marine natural product drug discovery efforts been productive and how can we improve their efficiency? , 2019, Expert opinion on drug discovery.

[24]  R. Awaluddin,et al.  Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study , 2020 .

[25]  S. Gayen,et al.  Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors , 2020, Journal of Molecular Structure.

[26]  S. Ciesek,et al.  Proteomics of SARS-CoV-2-infected host cells reveals therapy targets , 2020, Nature.

[27]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[28]  CHUN WEI YAP,et al.  PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..

[29]  A. O. Elzupir Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking , 2020, Journal of Molecular Structure.

[30]  V. Zupo,et al.  Ten-Year Research Update Review: Antiviral Activities from Marine Organisms , 2020, Biomolecules.

[31]  Vinicius M. Alves,et al.  QSAR Modeling of SARS‐CoV Mpro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2 , 2020, Molecular informatics.

[32]  A. Scala,et al.  Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study , 2020, Marine drugs.

[33]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[34]  Dongqing Wei,et al.  Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study , 2020, Journal of biomolecular structure & dynamics.

[35]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[36]  C. Maranas,et al.  Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity , 2020, Computational and Structural Biotechnology Journal.

[37]  Hualiang Jiang,et al.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors , 2020, Nature.

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  D. Blumenthal,et al.  Covid-19 - Implications for the Health Care System. , 2020, The New England journal of medicine.